Lipe & Dalton’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45
| Closed | -$40K | – | 99 |
|
|
2024
Q3 | $40K | Sell |
45
-11
| -20% | -$9.78K | 0.02% | 97 |
|
|
2024
Q2 | $51K | Hold |
56
| – | – | 0.03% | 93 |
|
|
2024
Q1 | $44K | Buy |
56
+11
| +24% | +$8.64K | 0.02% | 97 |
|
|
2023
Q4 | $26K | Buy |
+45
| New | +$26K | 0.01% | 98 |
|
|
2021
Q1 | – | Sell |
-100
| Closed | -$17K | – | 102 |
|
|
2020
Q4 | $17K | Hold |
100
| – | – | 0.01% | 96 |
|
|
2020
Q3 | $15K | Hold |
100
| – | – | 0.01% | 94 |
|
|
2020
Q2 | $16K | Hold |
100
| – | – | 0.01% | 93 |
|
|
2020
Q1 | $14K | Hold |
100
| – | – | 0.01% | 95 |
|
|
2019
Q4 | $13K | Hold |
100
| – | – | 0.01% | 103 |
|
|
2019
Q3 | $11K | Sell |
100
-10
| -9% | -$1.1K | 0.01% | 104 |
|
|
2019
Q2 | $12K | Hold |
110
| – | – | 0.01% | 97 |
|
|
2019
Q1 | $14K | Buy |
+110
| New | +$14K | 0.01% | 77 |
|